The Diabetic Neuropathy Market is experiencing robust growth as the global diabetes epidemic continues, neuropathic pain management innovation accelerates, and advanced therapeutic approaches including neuroprotective therapies and neuromodulation devices gain clinical acceptance. The global diabetic neuropathy market size was valued at USD 5.8 billion in 2024 and is projected to reach USD 8.74...